Advertisement

Rheumatology International

, Volume 31, Issue 7, pp 879–882 | Cite as

Effects of Spa therapy on serum leptin and adiponectin levels in patients with knee osteoarthritis

  • Antonella Fioravanti
  • Luca Cantarini
  • Maria Romana Bacarelli
  • Arianna de Lalla
  • Linda Ceccatelli
  • Patrizia Blardi
Original Article

Abstract

Adipocytokine, including leptin and adiponectin, may play an important role in the pathophysiology of osteoarthritis (OA). Spa therapy is one of the most commonly used non-pharmacological approaches for OA, but its mechanisms of action are not completely known. The aim of the present study was to assess whether spa therapy modified plasma levels of leptin and adiponectin in thirty patients with knee OA treated with a cycle of a combination of daily locally applied mud-packs and bicarbonate–sulphate mineral bath water. Leptin and adiponectin plasma levels were assessed at baseline and after 2 weeks, upon completion of the spa treatment period. The concentrations of leptin and adiponectin were measured by ELISA. At basal time, plasma leptin levels were significantly correlated with body mass index (BMI) and gender, but no significant correlation was found with patient age, duration of disease, radiographic severity of knee OA, VAS score or Lequesne index. There was no correlation between plasma adiponectin level and BMI, gender and age, duration of the disease, radiographic severity of knee OA and VAS score. A significant correlation of plasma adiponectin levels was found only with the Lequesne index. At the end of the mud-bath therapy cycle, serum leptin levels showed a slight but not significant increase, while a significant decrease (P < 0.05) in serum adiponectin levels was found. However, leptin and adiponectin concentrations after treatment were not correlated with other clinical parameters. In conclusion, our data show that spa therapy can modify plasma levels of the adipocytokines leptin and adiponectin, important mediators of cartilage metabolism. Whether this effect may play a potential role in OA needs further investigations.

Keywords

Osteoarthritis Leptin Adiponectin Spa therapy 

References

  1. 1.
    Henry BA, Clarke IJ (2008) Adipose tissue hormones and the regulation of food intake. J Neuroendocrinol 20:842–849PubMedCrossRefGoogle Scholar
  2. 2.
    Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919PubMedCrossRefGoogle Scholar
  3. 3.
    Loeser RF (2003) Systemic and local regulation of articular cartilage metabolism: where does leptin fit in the puzzle? Arthritis Rheum 48:3009–3012PubMedCrossRefGoogle Scholar
  4. 4.
    Lago R, Gomez R, Otero M, Lago F, Gallego R, Dieguez C et al (2008) A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage 16:1101–1109PubMedCrossRefGoogle Scholar
  5. 5.
    Presle N, Pottie P, Dumond H, Guillaume C, Lapicque F, Pallu S et al (2006) Differential distribution of adipokines between plasma and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage 14:690–695PubMedCrossRefGoogle Scholar
  6. 6.
    Sukenik S, Flusser D, Abu-Shakra M (1999) The role of spa therapy in various rheumatic diseases. Rheum Dis Clin North Am 25:883–897PubMedCrossRefGoogle Scholar
  7. 7.
    Sramek P, Simeckova M, Jansky L, Savlikova J, Vybiral S (2000) Human physiological responses to immersion into water of different temperatures. Eur J Appl Physiol 81:436–442PubMedCrossRefGoogle Scholar
  8. 8.
    Laatikainen T, Salminen K, Kohvakka A, Pettersson J (1988) Response of plasma endorphins, prolactin and catecholamines in women to intense heat in a sauna. Eur J Appl Physiol Occup Physiol 57:98–102PubMedCrossRefGoogle Scholar
  9. 9.
    Cima L, Cozzi F, Giusti P, Guidetti G, Todesco S (1992) Neuroendocrine effects of a cycle of fangotherapy. Pharmacol Rhes 26(suppl 1):302CrossRefGoogle Scholar
  10. 10.
    Cozzi F, Carrara M, Sfriso P, Todesco S, Cima L (2004) Anti-inflammatory effect of mud-bath application on adjuvant arthritis in rats. Clin Exp Rheumatol 22:763–766PubMedGoogle Scholar
  11. 11.
    Zeyl A, Stocks JM, Taylor NAS, Jenkins AB (2004) Interactions between temperature and human leptin physiology in vivo and in vitro. Eur J Appl Physiol 92:571–578PubMedCrossRefGoogle Scholar
  12. 12.
    Imbeault P, Dépault I, Haman F (2009) Cold exposure increases adiponectin levels in men. Metabolism 58:552–559PubMedCrossRefGoogle Scholar
  13. 13.
    Trayhurn P, Duncan JS, Hoggard N, Rayner DV (1998) Regulation of leptin production: a dominant role for the sympathetic nervous system? Proc Nutr Soc 57:413–419PubMedCrossRefGoogle Scholar
  14. 14.
    Miell JP, Englaro P, Blum WF (1996) Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects. Horm Metab Res 28:704–707PubMedCrossRefGoogle Scholar
  15. 15.
    Zumback MS, Boehme MW, Wahl P, Stremmel W, Zeigler R, Nawroth PP (1997) Tumour necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 82:4080–4082CrossRefGoogle Scholar
  16. 16.
    Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM (2004) Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 145:5589–5597PubMedCrossRefGoogle Scholar
  17. 17.
    Fioravanti A, Iacoponi F, Bellisai B, Cantarini L, Galeazzi M (2010) Short and long-term effect of Spa therapy in knee osteoarthritis. Am J Phys Med Rehabil 89:125–132PubMedCrossRefGoogle Scholar
  18. 18.
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the american rheumatism association. Arthritis Rheum 29:1039–1049PubMedCrossRefGoogle Scholar
  19. 19.
    Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502PubMedCrossRefGoogle Scholar
  20. 20.
    Blardi P, de Lalla A, D’Ambrogio T, Zappella M, Cevenini G, Ceccatelli L et al (2007) Rett syndrome and plasma leptin levels. J Pediatr 150:37–39PubMedCrossRefGoogle Scholar
  21. 21.
    Lequesne MG, Mery C, Samson M, Gerard P (1987) Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment tests. Scand J Rheumatol 65(suppl):85–89Google Scholar
  22. 22.
    Dougados M, Nguyen M, Listrat V, Amor B (1989) Score d’ équivalence des AINS. Rev Rhum Mal Osteoartic 56:251Google Scholar
  23. 23.
    Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P et al (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48:3118–3129PubMedCrossRefGoogle Scholar
  24. 24.
    van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB (2000) Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 8:25–33PubMedCrossRefGoogle Scholar
  25. 25.
    Otero M, Lago R, Lago F, Reino JJ, Gualillo O (2005) Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res Ther 7:R581–R591PubMedCrossRefGoogle Scholar
  26. 26.
    Simopoulou T, Malizos KN, Iliopoulos D, Stefanou N, Papatheodorou L, Ioannou M, Tsezou A (2007) Differential expression of leptin and leptin’s receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage;effect on cartilage metabolism. Osteoarthritis Cartilage 15:872–883PubMedCrossRefGoogle Scholar
  27. 27.
    Gomez R, Lago F, Gomez-Reino J, Dieguez C, Gualillo O (2009) Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases. J Mol Endocrinol 43:11–18PubMedCrossRefGoogle Scholar
  28. 28.
    Matsuzawa Y (2005) Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 6:7–14PubMedCrossRefGoogle Scholar
  29. 29.
    Ouchi N, Shibata R, Walsh K (2006) Cardioprotection by adiponectin. Trends Cardiovasc Med 16:141–146PubMedCrossRefGoogle Scholar
  30. 30.
    Puenpatom RA, Victor TW (2009) Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med 121:9–20PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Antonella Fioravanti
    • 1
  • Luca Cantarini
    • 1
  • Maria Romana Bacarelli
    • 1
  • Arianna de Lalla
    • 2
  • Linda Ceccatelli
    • 2
  • Patrizia Blardi
    • 2
  1. 1.Rheumatology Unit, Department of Clinical Medicine and Immunological SciencesUniversity of SienaSienaItaly
  2. 2.Center of Clinical PharmacologyUniversity of SienaSienaItaly

Personalised recommendations